annual working capital:
$231.18M+$18.55M(+8.72%)Summary
- As of today (May 29, 2025), KNSA annual working capital is $231.18 million, with the most recent change of +$18.55 million (+8.72%) on December 31, 2024.
- During the last 3 years, KNSA annual working capital has risen by +$79.56 million (+52.47%).
- KNSA annual working capital is now -23.30% below its all-time high of $301.40 million, reached on December 31, 2020.
Performance
KNSA Working capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly working capital:
$258.64M+$27.46M(+11.88%)Summary
- As of today (May 29, 2025), KNSA quarterly working capital is $258.64 million, with the most recent change of +$27.46 million (+11.88%) on March 31, 2025.
- Over the past year, KNSA quarterly working capital has increased by +$52.26 million (+25.32%).
- KNSA quarterly working capital is now -26.84% below its all-time high of $353.52 million, reached on September 30, 2020.
Performance
KNSA quarterly working capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Working capital Formula
Working Capital = Current Assets − Current Liabilities
KNSA Working capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +8.7% | +25.3% |
| 3 y3 years | +52.5% | +74.3% |
| 5 y5 years | +8.1% | +33.5% |
KNSA Working capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +52.5% | at high | +89.6% |
| 5 y | 5-year | -23.3% | +52.5% | -26.8% | +89.6% |
| alltime | all time | -23.3% | +679.1% | -26.8% | +771.6% |
KNSA Working capital History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $258.64M(+11.9%) |
| Dec 2024 | $231.18M(+8.7%) | $231.18M(+7.4%) |
| Sep 2024 | - | $215.35M(-0.6%) |
| Jun 2024 | - | $216.73M(+5.0%) |
| Mar 2024 | - | $206.38M(-2.9%) |
| Dec 2023 | $212.63M(+8.5%) | $212.63M(+4.9%) |
| Sep 2023 | - | $202.64M(+2.1%) |
| Jun 2023 | - | $198.57M(+1.9%) |
| Mar 2023 | - | $194.91M(-0.6%) |
| Dec 2022 | $195.99M(+29.3%) | $195.99M(+5.8%) |
| Sep 2022 | - | $185.32M(+35.9%) |
| Jun 2022 | - | $136.39M(-8.1%) |
| Mar 2022 | - | $148.40M(-2.1%) |
| Dec 2021 | $151.62M | $151.62M(-17.2%) |
| Sep 2021 | - | $183.09M(-11.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2021 | - | $206.03M(-14.2%) |
| Mar 2021 | - | $240.11M(-20.3%) |
| Dec 2020 | $301.40M(+41.0%) | $301.40M(-14.7%) |
| Sep 2020 | - | $353.52M(+44.9%) |
| Jun 2020 | - | $243.94M(+25.9%) |
| Mar 2020 | - | $193.71M(-9.4%) |
| Dec 2019 | $213.80M(-21.2%) | $213.80M(-11.2%) |
| Sep 2019 | - | $240.78M(-9.6%) |
| Jun 2019 | - | $266.28M(-10.7%) |
| Mar 2019 | - | $298.06M(+9.9%) |
| Dec 2018 | $271.20M(+813.9%) | $271.20M(-13.5%) |
| Sep 2018 | - | $313.51M(-8.0%) |
| Jun 2018 | - | $340.73M(+67.7%) |
| Mar 2018 | - | $203.19M(+584.7%) |
| Dec 2017 | $29.67M(-45.1%) | $29.67M |
| Dec 2016 | $54.03M | - |
FAQ
- What is Kiniksa Pharmaceuticals annual working capital?
- What is the all time high annual working capital for Kiniksa Pharmaceuticals?
- What is Kiniksa Pharmaceuticals annual working capital year-on-year change?
- What is Kiniksa Pharmaceuticals quarterly working capital?
- What is the all time high quarterly working capital for Kiniksa Pharmaceuticals?
- What is Kiniksa Pharmaceuticals quarterly working capital year-on-year change?
What is Kiniksa Pharmaceuticals annual working capital?
The current annual working capital of KNSA is $231.18M
What is the all time high annual working capital for Kiniksa Pharmaceuticals?
Kiniksa Pharmaceuticals all-time high annual working capital is $301.40M
What is Kiniksa Pharmaceuticals annual working capital year-on-year change?
Over the past year, KNSA annual working capital has changed by +$18.55M (+8.72%)
What is Kiniksa Pharmaceuticals quarterly working capital?
The current quarterly working capital of KNSA is $258.64M
What is the all time high quarterly working capital for Kiniksa Pharmaceuticals?
Kiniksa Pharmaceuticals all-time high quarterly working capital is $353.52M
What is Kiniksa Pharmaceuticals quarterly working capital year-on-year change?
Over the past year, KNSA quarterly working capital has changed by +$52.26M (+25.32%)